3,4-methylenedioxyamphetamine has been researched along with Serotonin Syndrome in 3 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Serotonin Syndrome: An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ronan, GP | 1 |
| Ronan, N | 1 |
| McGettigan, S | 1 |
| Browne, G | 1 |
| Warrick, BJ | 1 |
| Wilson, J | 1 |
| Hedge, M | 1 |
| Freeman, S | 1 |
| Leonard, K | 1 |
| Aaron, C | 1 |
| Felgenhauer, N | 1 |
| Zilker, T | 1 |
1 review available for 3,4-methylenedioxyamphetamine and Serotonin Syndrome
| Article | Year |
|---|---|
[Poisoning with amphetamines and designer drugs].
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Designer Drugs; Drug Overdose; Humans; Illicit Drugs; I | 1999 |
2 other studies available for 3,4-methylenedioxyamphetamine and Serotonin Syndrome
| Article | Year |
|---|---|
Serotonin syndrome unmasking thyrotoxicosis.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Aftercare; Anti-Arrhythmia Agents; Antithyroid Agents; Carbima | 2019 |
Lethal serotonin syndrome after methylone and butylone ingestion.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Fatal Outcome; Female; Humans; Methamphetamine; N-Methyl-3,4-m | 2012 |